![]() |
市场调查报告书
商品编码
1819879
2025-2033年兽医传染病诊断市场报告(依技术、动物类型、感染类型、最终用户和地区)Veterinary Infectious Disease Diagnostics Market Report by Technology, Animal Type, Infection Type, End User, and Region 2025-2033 |
2024年,全球兽医传染病诊断市场规模达22亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到41亿美元,2025-2033年期间的复合年增长率(CAGR)为7.2%。宠物和牲畜疾病盛行率的上升、宠物主人意识的提升、技术进步的迅速发展、对精准诊断的需求、先进工具的采用、宠物健康问题的日益关注、兽医基础设施的不断扩展、政府在人畜共患疾病预防方面的倡议以及研究资金的增加,都是推动市场增长的因素。
宠物和牲畜传染病的盛行率不断上升
宠物和牲畜中传染病的日益普及正在加速市场成长。例如,猫白血病病毒 (FeLV) 是猫中最常见的传染病之一,影响美国和加拿大 2-3% 的猫科动物。宠物与人之间互动的增加进一步加剧了疾病传播的风险。此外,快速的城市化、畜牧业模式的改变以及确诊患者数量的增加也推动了市场的成长。推动兽医传染病诊断市场价值成长的另一个因素是,对准确及时的诊断方法的需求日益增长,这有助于有效控制和遏制这些疾病。
提高宠物主人的意识
宠物主人对早期疾病检测重要性的认识不断提高,是推动市场成长的关键因素。随着宠物被视为家庭不可或缺的成员,主人越来越重视它们的健康和福祉。这种认识的提高导致对定期健康检查、预防措施和早期诊断测试的需求日益增长。此外,先进诊断工具和技术的普及使宠物主人更容易获得高品质的兽医护理,进一步推动了对传染病诊断的需求。
技术进步
根据市场概况,由于技术的快速进步,兽医传染病诊断的需求正在大幅增长。诊断技术的进步极大地提高了诊断效率和结果准确性,进一步推动了市场的成长。此外,旨在提高动物传染病检测和鑑定能力的聚合酶炼式反应 (PCR) 等分子诊断技术的引入,也促进了市场的成长。此外,自动化分析仪和远距医疗平台等数位医疗工具的引入简化了诊断流程,也进一步支持了市场的成长。
免疫诊断占大部分市场份额
根据兽医传染病诊断市场研究报告,由于对精准疾病检测的需求不断增长,免疫诊断领域占据了最大的市场份额。免疫诊断测试,包括酵素连结免疫吸附试验 (ELISA) 和免疫萤光试验 (IFA),因其能够特异性检测与传染病相关的抗体或抗原而至关重要。这种精确度对于识别病原体和早期诊断疾病至关重要,这对于有效的治疗和疾病管理至关重要。随着兽医护理日益复杂,人们对能够快速提供明确结果的高度可靠的诊断工具的期望也日益增长。宠物和牲畜传染病的不断蔓延,也加剧了对此类精准诊断解决方案的需求。
伴侣动物占据该产业最大份额
兽医传染病诊断市场中的伴侣动物细分市场的发展得益于人们对宠物健康和福祉的关注,以及诊断技术的进步。此外,宠物主人越来越重视早期疾病检测,他们更加意识到主动健康管理的益处,这也推动了市场的成长。这种意识的增强导致对能够在疾病恶化之前发现疾病的诊断服务的需求不断增长,从而改善宠物的健康状况。该细分市场也受到先进诊断工具的推动,例如分子检测和快速即时检测,这些工具能够提供准确及时的诊断结果。这些创新使兽医能够更有效地诊断和治疗感染,从而提高伴侣动物的整体护理品质。
细菌感染是主要的细分市场
兽医传染病诊断市场中的细菌感染细分市场受动物细菌性疾病日益流行的推动,这需要先进的诊断工具来实现有效的管理和控制。宠物和牲畜中钩端螺旋体病、结核病和沙门氏菌等细菌感染的发生率不断上升,催生了对精准诊断解决方案的需求。人们日益意识到细菌性疾病对动物健康和生产力的影响,这也推动了对可靠诊断方法的需求,以确保早期发现和介入。此外,由于牲畜细菌感染可能导致食品供应污染,对食品安全关注度的转变也推动了该细分市场的发展,这促使对检测和监控提出了更严格的要求。兽医保健基础设施和服务的扩展,尤其是在新兴经济体,透过提高诊断技术的可近性,支持了该细分市场的成长。
参考实验室占据市场主导地位
兽医传染病诊断市场中参考实验室细分市场的发展受到诊断检测需求日益复杂化的驱动。随着兽医诊断技术日益复杂,参考实验室因其先进的检测能力和专业知识而日益受到重视。市场对能够区分各种病原体和疾病的精确、全面的诊断检测的需求日益增长,这推动了该细分市场的发展。这种复杂性要求使用高度专业化的设备和熟练的人员,而这正是参考实验室的标誌。此外,该细分市场受益于需要进行全面、高解析度分析的诊断样本数量的不断增长,这进一步凸显了对参考实验室的需求。对分子诊断和基因组分析等先进检测方法的需求不断增长,推动了对能够进行高精度检测的专业参考实验室的需求。
北美引领市场,占据兽医传染病诊断市场最大份额
该报告还对所有主要区域市场进行了全面分析,包括北美(美国和加拿大);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。报告指出,北美是兽医传染病诊断最大的区域市场。
北美兽医传染病诊断市场的发展受到宠物和牲畜传染病日益普及的推动。该地区犬瘟热、猫白血病和各种人畜共通传染病发病率的上升,凸显了对有效诊断解决方案的需求。宠物主人对早期发现和预防疾病重要性的认识不断提高,也推动了该地区市场的发展。北美的宠物主人对宠物健康的了解程度更高,也更加积极主动,这刺激了对先进诊断服务的需求。此外,兽医诊断领域的技术进步日新月异,包括分子生物学、快速检测方法和自动化分析仪的创新,正在支撑市场的成长。这些进步提高了诊断过程的准确性、速度和效率。此外,市场也受到对兽医研发 (R&D) 日益增长的关注的推动,这得到了来自私营和公共部门的大量投资支持。
(请注意,这只是关键参与者的部分名单,完整名单将在报告中提供。)
The global veterinary infectious disease diagnostics market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.1 Billion by 2033, exhibiting a growth rate (CAGR) of 7.2% during 2025-2033. Increasing disease prevalence in pets and livestock, rising pet owner awareness, surging technological advancements, the need for accurate diagnostics, adoption of advanced tools, heightened pet health concerns, expanding veterinary infrastructure, government initiatives for zoonotic disease prevention, and enhanced research funding are factors fueling the market growth.
Growing Prevalence of Infectious Diseases in Pets and Livestock
Increasing prevalence of infectious diseases among pets and livestock is accelerating the market growth. For instance, feline leukemia virus (FeLV) is one of the most common infectious diseases in cats, affecting between 2-3% of felines in the US and Canada. The risk is further amplified by the surging interactions among pets and humans, which is further escalating the chances of disease transmission. Moreover, the rapid urbanization, changes in animal husbandry practices, and the rising number of diagnosed patients are supporting the market growth. Another factor boosting the veterinary infectious disease diagnostics market value is the burgeoning demand for accurate and timely diagnostics that can assist with efficient control and containment of these diseases.
Increasing Awareness Among Pet Owners
Rising awareness among pet owners about the importance of early disease detection is a crucial factor driving the market growth. With pets being considered integral family members, owners are increasingly prioritizing their health and well-being. This heightened awareness has led to a growing demand for regular health check-ups, preventive measures, and early diagnostic tests. Additionally, the availability of advanced diagnostic tools and technologies has made it easier for pet owners to access high-quality veterinary care, further driving the demand for infectious disease diagnostics.
Technological Advancements
According to the market overview, veterinary infectious disease diagnostics are witnessing considerably demand due to rapid technological advancements. Improvements in diagnostic have greatly improved the efficiency and accuracy of the results, which is further fueling the market growth. Furthermore, the introduction of molecular diagnostic technologies, such as polymerase chain reaction (PCR), designed to improve detection and identification in animal infectious diseases is facilitating the market growth. Apart from this, the incorporation of digital health tools, such as automated analyzers and telemedicine platforms, have simplified the diagnostics process, which is further supporting the market growth.
Immunodiagnostics accounts for the majority of the market share
According to the veterinary infectious disease diagnostics market research report, the immunodiagnostics segment holds the largest market share due to the increasing demand for accurate disease detection. Immunodiagnostic tests, including enzyme-linked immunosorbent assays (ELISA) and immunofluorescence assays (IFA), are essential for their ability to specifically detect antibodies or antigens related to infectious diseases. This precision is critical in identifying pathogens and diagnosing diseases at early stages, which is crucial for effective treatment and disease management. As veterinary care becomes more sophisticated, there is a growing expectation for highly reliable diagnostic tools that can provide definitive results quickly. The escalating prevalence of infectious diseases in pets and livestock has heightened the need for such accurate diagnostic solutions.
Companion animals holds the largest share of the industry
The companion animals segment in the veterinary infectious disease diagnostics market is driven by the focus on pet health and wellness, as well as advancements in diagnostic technology. Furthermore, the increasing prioritization of early disease detection by pet owners, who are more aware of the benefits of proactive health management are driving the market growth. This heightened awareness results in a growing demand for diagnostic services that can identify diseases before they become severe, leading to better health outcomes for pets. The segment is also driven by the availability of advanced diagnostic tools, such as molecular assays and rapid point-of-care tests, which offer accurate and timely results. These innovations enable veterinarians to diagnose and treat infections more effectively, enhancing the overall quality of care for companion animals.
Bacterial infections represent the leading market segment
The bacterial infections segment in the veterinary infectious disease diagnostics market is driven by the burgeoning prevalence of bacterial diseases among animals, which necessitates advanced diagnostic tools for effective management and control. The rising incidence of bacterial infections such as leptospirosis, tuberculosis, and salmonella in both pets and livestock fuels demand for precise diagnostic solutions. The growing awareness of the impact of bacterial diseases on animal health and productivity also drives the need for robust diagnostic methods to ensure early detection and intervention. Additionally, the segment is driven by the shifting focus on food safety, as bacterial infections in livestock can lead to contamination of the food supply, prompting stringent testing and monitoring requirements. The expansion of veterinary healthcare infrastructure and services, particularly in emerging economies, supports the growth of this segment by enhancing access to diagnostic technologies.
Reference laboratories dominates the market
The reference laboratories segment in the veterinary infectious disease diagnostics market is driven by the escalating complexity of diagnostic testing requirements. As veterinary diagnostics become more sophisticated, reference laboratories are increasingly relied upon for their advanced capabilities and specialized expertise. The segment is driven by the surging need for accurate and comprehensive diagnostic tests that can differentiate between various pathogens and diseases. This complexity necessitates the use of highly specialized equipment and skilled personnel, which are hallmarks of reference laboratories. Additionally, the segment benefits from the increasing volume of diagnostic samples that require thorough and high-resolution analysis, further underscoring the need for reference laboratories. The rising demand for advanced testing methods, such as molecular diagnostics and genomic analysis, drives the need for specialized reference laboratories capable of conducting these tests with high precision.
North America leads the market, accounting for the largest veterinary infectious disease diagnostics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for veterinary infectious disease diagnostics.
The North American veterinary infectious disease diagnostics market is driven by the growing prevalence of infectious diseases among pets and livestock. The rising incidence of diseases such as canine distemper, feline leukemia, and various zoonotic infections in the region underscores the need for effective diagnostic solutions. The regional market is also driven by the burgeoning awareness among pet owners about the importance of early detection and prevention of diseases. Pet owners in North America are more informed and proactive about their pets' health, which fuels demand for advanced diagnostic services. Moreover, the surging technological advancements in veterinary diagnostics, including innovations in molecular biology, rapid testing methods, and automated analyzers, are supporting the market growth. These advancements enhance the accuracy, speed, and efficiency of diagnostic processes. Apart from this, the market is driven by the escalating focus on veterinary research and development (R&D), supported by substantial investments from both private and public sectors.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)